ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MO vs ABBV // ENTERPRISE SCALE & MARKET CAP

Altria Group Inc. (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: MO 8 — ABBV 7
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ABBV
market-cap
$128.15B
market-cap
$513.86B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MO VS. ABBV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MO ABBV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.50% 70.20% -7.70 ABBV /gross-margins <GO>
Return on Invested Capital (ROIC) 48.40% 29.00% +19.40 MO /roic <GO>
EV/EBITDA & P/E Valuation 14.7x 33.3x -18.60 MO /valuation <GO>
Free Cash Flow Yield 7.08% 3.47% +3.61 MO /fcf-yield <GO>
Operating Margin 42.50% 24.60% +17.90 MO /operating-margins <GO>
Net Profit Margin 29.80% 6.90% +22.90 MO /net-margins <GO>
Revenue Growth (YoY) -3.10% 8.60% -11.70 ABBV /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 5.43% 2.27% +3.16 MO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.90 5.33 -0.43 ABBV /balance-sheet <GO>
Piotroski F-Score Quality 6/9 7/9 -1.00 ABBV /piotroski-score <GO>
Options Implied Move & Put/Call Skew 6.60% 7.40% -0.80 MO /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 69.7 72.8 -3.06 ABBV /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.92 1.15 -0.23 ABBV /macro-sensitivity <GO>
Forward P/E Multiple 17.1x 113.1x -96.00 MO /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $128.15B $513.86B -$385.71B ABBV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MO REV ABBV REV MO GROSS % ABBV GROSS % MO FCF ABBV FCF
FY 2025 $23.28B $61.16B 62.5% 70.2% $9.07B $17.82B
FY 2024 $24.02B $56.33B 59.8% 70.0% $8.61B $17.83B
FY 2023 $24.48B $54.32B 44.0% 44.0% $8.19B $20.39B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MO // BETA 0.92
ABBV // BETA 1.15